A Novel Quantitative Urine LAM Antigen Strip for Point-of-care Tuberculosis Diagnosis in Non-Hiv Adults.

Zhen Huang,Huan Huang,Jing Hu,Lu Xia,Xuhui Liu,Rong Qu,Xiaolin Huang,Yang,Kang Wu,Ruiqing Ma,Jinchuan Xu,Zhenyan Chen,Yuhao Wu,Juan Yang,Yong Fang,Jianfeng Zeng,Weihua Lai,Guodong Sui,Wei Sha,Yonghua Xiong,Shuihua Lu,Xiao-Yong Fan

DOI: https://doi.org/10.1016/j.jinf.2023.11.014

IF: 28.2

2024-01-01

Journal of Infection

Abstract:We read with interest the systematic review by Ashar et al. in which the implementation of lateral flow lipoarabinomannan (LAM)-based tuberculosis (TB) testing among HIV-positive inpatients is recommended.1 Detecting urinary LAM may represent a promising approach to address the gap in TB diagnosis,2 which is rapid, economical, and available at point-of-care (POC) and utilizes non-sputum samples to cater to populations who have difficulty producing diagnostic sputum samples.1,3 However, limited sensitivity has impeded its widespread adoption.